ABBV vs DXCM
AbbVie vs Dexcom — AI-powered side-by-side comparison
| Metric | ABBV | DXCM |
|---|---|---|
| AI Score | 52 | 58 |
| Price | $243.70 | $86.92 |
| P/E Ratio | 69.05× | 33.71× |
| ROE | -129.2% | 30.5% |
| Revenue Growth YoY | — | — |
| Gross Margin | 74.1% | 62.5% |
| Debt / Equity | 2.47× | 0.51× |
| Dividend Yield | 2.8% | 0.0% |
| RSI (14) | 33.5 | 81.8 |
| Beta | 0.28 | 1.453 |
| Expected Upside | — | +1.1% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ABBV Full Analysis
DXCM Full Analysis